| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |